Genialis is a pioneering bioinformatics company dedicated to accelerating therapeutic development through artificial intelligence and machine learning. They specialize in analyzing complex multi-omics data to uncover novel biomarkers, predict patient responses to therapies, and optimize clinical trial designs. Genialis's flagship platform, ResponderID™, empowers biopharmaceutical companies to make data-driven decisions, ultimately advancing precision medicine and bringing effective treatments to patients faster.
Serves as a key U.S. operational base, focusing on business development, strategic partnerships, client engagement, and supporting R&D efforts within the North American biopharma market.
Situated within BioLabs@CIC, providing access to shared state-of-the-art laboratory and office facilities, fostering a collaborative and innovative environment alongside other biotech startups.
Characterized by a dynamic, innovative, and collaborative startup culture. Emphasis on scientific excellence, agile development, and teamwork to address complex bioinformatics challenges in drug discovery.
Its Cambridge location places Genialis at the epicenter of one of the world's foremost biotechnology clusters, offering unparalleled access to research institutions, pharmaceutical partners, and specialized talent.
Genialis supports biopharmaceutical companies globally in their drug discovery and development efforts through its advanced bioinformatics platforms and data science expertise. With key operational hubs in the USA (Cambridge, MA and Houston, TX) and Europe (Ljubljana, Slovenia), Genialis offers its AI-powered solutions and services to a worldwide clientele, enabling biomarker discovery and translational research across international markets.
One Broadway, 14th Floor
Cambridge
MA
USA
Address: Tehnološki park 19, 1000 Ljubljana, Slovenia
Leverages Slovenia's strong tech talent pool for software engineering and bioinformatics, and acts as a base for European market expansion, operations, and research activities.
Address: BioLabs Houston, 2450 Holcombe Blvd Suite X, Houston, TX 77021, USA
To tap into the growing biotech and life sciences sector in Houston and the broader Texas region, fostering partnerships and client relationships, and supporting clinical research collaborations.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Genialis' leadership includes:
Genialis has been backed by several prominent investors over the years, including:
In the past year, Genialis has strengthened its leadership team by appointing Dr. Gerrit Klaerner as Chief Business Officer to drive commercial strategy and Dr. Stephan Brock as Chairman of the Board to provide strategic governance, reflecting the company's growth trajectory.
Discover the tools Genialis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Genialis primarily utilizes the email format [first].[last]@genialis.com (e.g., jane.doe@genialis.com). This is the most common pattern observed for company employees. Other formats may exist but are less frequent.
[first].[last]@genialis.com
Format
jane.doe@genialis.com
Example
85%
Success rate
Business Wire • July 12, 2023
Genialis announced the appointment of Dr. Stephan Brock as an independent Chairman of its Board of Directors. Dr. Brock's extensive experience in life sciences, diagnostics, and biopharma is expected to be invaluable for Genialis's commercial expansion and platform development....more
Genialis Newsroom • June 1, 2023
Genialis and Debiopharm announced a collaboration to develop a novel machine learning-powered clinical diagnostic test. The test, built on Genialis's ResponderID platform, aims to predict patient response to Debiopharm's investigational cancer therapies, advancing precision medicine in oncology....more
Business Wire • May 16, 2023
Genialis announced the appointment of Gerrit Klaerner, Ph.D., MBA, as its Chief Business Officer (CBO). Dr. Klaerner will lead Genialis’ commercial strategy, focusing on sales, marketing, and partnerships to drive the adoption of its AI/ML-enabled platform, ResponderID™....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Genialis, are just a search away.